Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtype

11 Apr 2017

Abstract excerpt

// Yujin Kwon 1, * , Minhee Park 1, * , Mi Jang 1, * , Seongju Yun 1 , Won Kyu Kim 1 , Sora Kim 2 , Soonmyung Paik 2 , Hyun Jung Lee 3 , Sungpil Hong 3 , Tae Il Kim 3 , Byungsoh Min 4 and Hoguen Kim 1 1 Department of Pathology and BK21 for Medical Science, Yonsei University College of Medicine, Seoul, Korea 2 Severance Biomedical Science Institute and BK21 for Medical Science, Yonsei University College of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Colorectal Cancer Treatments and Studies
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28455965
DOI: 10.18632/oncotarget.17023

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognosis of stage III colorectal carcinomas with FOLFOX adjuvant chemotherapy can be predicted by molecular subtypePMID 28455965Read ↗

A consensus molecular subtypes classification strategy for clinical colorectal cancer tissuesSemantic proximity Read ↗

Development of molecular subtype specific prognostic marker signature in immune response associated colon cancer through fuzzy based transcriptomic approachSemantic proximity Read ↗

Classification of colon cancer patients into Consensus Molecular Subtypes using Support Vector MachinesSemantic proximity Read ↗

Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer Samples into Molecular SubtypesSemantic proximity Read ↗

Investigation of colorectal cancer in accordance with consensus molecular subtype classificationSemantic proximity Read ↗

Reconciliation of classification systems defining molecular subtypes of colorectal cancerSemantic proximity Read ↗

Consensus molecular subtypes of colorectal cancer in clinical practice: A translational approachSemantic proximity Read ↗

Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities.Semantic proximity Read ↗

The Evolving Role of Consensus Molecular Subtypes: a Step Beyond Inpatient Selection for Treatment of Colorectal Cancer.Semantic proximity Read ↗

Molecular profiling of risk factors for relapse in Japanese patients with stage II colorectal cancer: a retrospective cohort study.Semantic proximity Read ↗

Immune Characteristics-Related Typing of Colorectal Cancer and the Establishment of 14-Gene Prognostic ModelSemantic proximity Read ↗

Genetic Molecular Subtypes in Optimizing Personalized Therapy for Metastatic Colorectal Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.